Catalent
CTLT
#1518
Rank
โ‚น977.85 B
Marketcap
โ‚น5,387
Share price
0.65%
Change (1 day)
54.87%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น823.87 Billion

According to Catalent's latest financial reports the company's total assets are โ‚น823.87 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30โ‚น884.52 B6.69%
2022-06-30โ‚น829.06 B22.48%
2021-06-30โ‚น676.90 B14.98%
2020-06-30โ‚น588.71 B38.07%
2019-06-30โ‚น426.38 B37.49%
2018-06-30โ‚น310.13 B38.58%
2017-06-30โ‚น223.78 B7.39%
2016-06-30โ‚น208.38 B4.2%
2015-06-30โ‚น199.98 B7.79%
2014-06-30โ‚น185.52 B5.66%
2013-06-30โ‚น175.59 B0.77%
2012-06-30โ‚น174.24 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น113.94 B-86.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.87 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.040 T 26.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น33.36 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA